[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100552526":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":27,"locations":37,"responsibleParty":55,"collaborators":59,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":24,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":24,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":81,"overallStatus":40,"whyStopped":24,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Universiti Sains Malaysia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Probiotic","EXPERIMENTAL","Bifidobacterium infantis YLGB-1496 at 1x10 log CFU\u002Fday for 12 weeks",[13],"Dietary Supplement: Probiotic",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Intervention consists of daily administration of 2g of maltodextrin, administered daily for 12-weeks)",[19],"Dietary Supplement: Placebo",[21,25],{"type":22,"name":9,"description":11,"armGroupLabels":23,"otherNames":24},"DIETARY_SUPPLEMENT",[9],null,{"type":22,"name":15,"description":17,"armGroupLabels":26,"otherNames":24},[15],[28,33],{"name":29,"role":30,"phone":31,"phoneExt":24,"email":32},"Adli Ali, MD","CONTACT","603 8921 5555","adli.ali@ppukm.ukm.edu.my",{"name":34,"role":30,"phone":35,"phoneExt":24,"email":36},"Min Tze Liong, PhD","604 653 2114","mintze.liong@usm.my",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":24,"geoPoint":24,"contacts":46},"UKM Medical Centre","RECRUITING","Cheras","Kuala Lumpur","56000","Malaysia","MY",[47,49,52,54],{"name":48,"role":30,"phone":31,"phoneExt":24,"email":32},"Adli Adli, MD",{"name":50,"role":51,"phone":24,"phoneExt":24,"email":24},"Fahisham Taib, MD","SUB_INVESTIGATOR",{"name":53,"role":51,"phone":24,"phoneExt":24,"email":24},"Intan Juliana Abd. Hamid, MD",{"name":34,"role":51,"phone":24,"phoneExt":24,"email":24},{"type":56,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"SPONSOR_INVESTIGATOR","Min-Tze LIONG","Professor",[60],{"name":61,"class":6},"National University of Malaysia","100552526","phase-2-modulation-of-gut-microbiota-by-probiotic-in-children-100552526",false,"NCT06474234","Modulation of Gut Microbiota by Probiotic in Children","Inclusion criteria\n\n* Preschool children (\\\u003C7 years old)\n* Born full-term (≥37 weeks delivered)\n* In generally good health as determined by the investigator\n\nExclusion criteria\n\n* Had taken probiotics or prebiotics within past 4-weeks\n* Had taken milk powder or supplements containing probiotics within past 4-weeks\n* History of using antibiotic within past 4-weeks\n* Suffering from serious acute or chronic diseases (cardiovascular disease, gastrointestinal disease, endocrine disease, immune system disease, metabolic disease, etc.)\n* Using other drugs that may interfere with the experimental results\n* Participated in other experimental trials less than 8-weeks prior to this study",true,"ALL","1 Month","7 Years",{"count":73,"type":74},120,"ESTIMATED","INTERVENTIONAL",[77],"PHASE2","This project aims to study the benefits of probiotics namely Bifidobacterium infantis YLGB-1496 in modulating gut microbiota of healthy children, among pre-school children in Malaysia \\\u003C7 years old.",[80],"Generally Healthy",[82,83,84],"Bifidobacterium","probiotic","children","2024-06-19",{"date":87,"type":88},"2024-06-25","ACTUAL",{"date":90,"type":88},"2024-05-29",{"date":92,"type":74},"2025-06-30",{"name":57,"class":6},1]